We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Portable Rapid Diagnostic Assay Identifies Hemorrhaging Patients Using Small Blood Sample

By LabMedica International staff writers
Posted on 29 Aug 2023
Print article
Image: A prototype of the portable internal hemorrhage diagnostic tool for prehospital settings (Photo courtesy of DioTeX)
Image: A prototype of the portable internal hemorrhage diagnostic tool for prehospital settings (Photo courtesy of DioTeX)

Hemorrhaging occurs when blood vessels are damaged due to a traumatic event, leading to either visible external or hidden internal bleeding. While external bleeding is easily detectable, internal bleeding, also referred to as internal hemorrhaging, remains hidden from plain sight. Diagnosing internal bleeding demands clinical suspicion and subsequent assessment. Within hospital settings, advanced imaging can confirm these assessments, enabling timely surgical intervention to save lives. However, current methods for detecting hemorrhage are insufficient and require skilled operators, presenting significant diagnostic challenges. Now, a revolutionary internal hemorrhage diagnostic tool could change all that.

DioTeX Diagnostics (Baltimore, MD, USA), comprising a team of undergraduate biomedical engineers from Johns Hopkins University (Baltimore, MD, USA), is developing a portable, dependable, and accessible internal hemorrhage diagnostic tool. Their approach involves using a specific biomarker associated with hemorrhage to create a rapid immunochemistry-based test. By analyzing a small blood sample, this tool can swiftly identify patients with internal bleeding. This test has the potential to revolutionize internal hemorrhage diagnosis, as it can be conducted accurately and consistently by individuals with minimal training. This innovation holds the promise of faster and more appropriate hemorrhage care, potentially saving thousands of lives annually.

DioTeX has built a prototype of its portable rapid diagnostic assay designed to detect blood biomarkers linked to trauma-induced hemorrhage. This advancement aims to enhance the evaluation and management of internal trauma. Using the device, critical diagnostic results can be obtained and interpreted by anyone, regardless of location. To utilize the device, a blood sample is collected from behind the ear of a patient who may be experiencing internal bleeding. This process employs DioTeX's proprietary blood drawing mechanism. After approximately 5 minutes, users can interpret the test device's reading. A single line indicates no hemorrhage, while two lines indicate the presence of bleeding. The testing device requires minimal training, making it practical for use in settings with limited resources and in rural areas.

Related Links:
DioTeX Diagnostics 
Johns Hopkins University 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.